Fintech PR
ARTEIA launches its utility token, ARTK, and a peer-to-peer platform
Reading Time: 4 minutes
Arteia announces the launch of its ICO (Initial Coin Offering). Arteia offers the first comprehensive, advanced technology platform set to empower art collectors by linking a collection management system to a matching platform supported by a provenance tracker. Arteia Collect, launched in October 2018, is the ultimate cataloguing solution to manage any kind of collections and was created by collectors for collectors.
Arteia will open at the end of the ICO it’s decentralized platform allowing art market’s actors to interact around a provenance ledger, to share, study, inventorize, lend and trade artworks through matching marketplaces, in a tokenized ecosystem.
Founded in 2016 in Brussels, and with its first product, Arteia Collect, launched in October 2018, Arteia’s project stems from the desire to bring more transparency and more security to the art world, the project is led by a mix of experts from the art, business and tech field. Its founders, Philippe Gellman (CEO), Marek Zabicki (CTO) and Olivier Marian (CSO),are entrepreneurs and experienced collectors.
Unlike any other known project, the Arteia platform’s MVP will be fully functional at the end of the ICO and will already offer the 5 use cases described in the white paper to the token holders.
“We raised already EUR 3 million since the creation of the company to develop our working platform and we are onboarding new collectors every week. Now it’s time to rocket our project on an international basis and an ICO seemed the mos accurate way to get the necessary means and develop a whole tokenized eco-system. We will bring more efficiency and liquidity on the secondary market with much lower fees than on the actual Art market and more transparency creating a universal ledger by anchoring in the Blockchain the provenance of Art pieces.
The Arteia solution powered by our ICO is a promise of greater transparency and more equal distribution for the art market,” comments Philippe Gellman, the CEO of Arteia.
Arteia: the solution for an art market looking for innovation
The art market is one of the last still barely touched by the digital revolution. Art is a very profitable asset class, and art sales have been booming in the past years, partly due to the gradual introduction of online sales and online-only auctions.
However, the market lacks transparency related to artwork provenance, price-setting and commission fees. These problems pave the way for blockchain technology to make a critical and long-lasting impact on the industry by bringing more trust and liquidity to the art market.
Arteia has developed an innovative decentralized peer-to-peer service for artists, collectors, and professionals of the fine art ecosystem: a comprehensive platform to serve the needs of all the actors in the art market.
In this sense, we are proud to have already been able to develop partnerships and solutions with key respected actors in the sector, such as our joint venture with Cahiers d’Art, RAISONLINE, that will be the first digital catalogue Raisonnesolution anchored to the blockchain.
We create the art world of tomorrow
The total pool of token for this operation is fixed at 400,000,000 (four hundred million) ARTK, the Soft cap for this operation is settled at US $3.5 million and the Hard cap is at US $15 million. 50% of the tokens will be sold during the ICO.
Token prices will be fixed shortly before the pre-sale and the main sale according to BTC and ETH volatily.
This ICO will be one of the first offering where all 5 use cases described in the Whitepaper will be running and available for token buyers at the end of the fundraising sale period when the toekens are issued.
What use for the ARTK token?
The ARTK token will allow its owner to subscribe to and access the platform’s services directly after the ICO. It will also manage the access to the provenance tracker where artists and estates will be able to store publicly and securely the provenance of their artworks.
The five use cases that will be available for token holders will be:
- Subscription to the cataloging solution.
- Provenance: adding provenance details of an artwork by the users and consulting the provenance of an artwork.
- Matching and allowing both parties to agree on the details of a transaction in a secure and trusted environment provided by smart-contracts powered by the ARTK token.
- Lending: allowing collectors to safely lend his artworks to museums and exhibitions.
- Showcase: creating a public or private showcase and gain recognition or just share the passion.
In the long run, Arteia’s goal is to become a global platform for the art market actors, with a marketplace supported by our provenance ledger, to trade art works in fiat or crypto currencies. Such a platform will help the digital world of token and crypto to connect with the physical field of art.
“Cofounded by collectors and engineers, Arteia uses the finest and latest technologies — including blockchain — to suit the needs of all the actors of the art world. Our teams have been working for three years to develop this product, which is already used by artists and galleries. More than 30 000 artworks are already onboarded,“ explains Philippe Gellman, CEO Arteia
Blockchain technologies for the highest possible level of trust, security and confidentiality
Created by collectors to meet their needs, Arteia knows the extent to which the security and confidentiality of art collections are foremost. This is why Arteia’s access is protected by Two-Factor Authentication and allows the user to decide where the data is stored (on various hosted servers around the world, or on a personal server disconnected from the Internet).
Arteia also leverages on blockchain technologies to develop its artwork provenance tracker, creating an immutable history of each artwork life. This provenance database will serve as a tool to verify the authenticity of an artwork and to establish the value of the piece. Dealing with artworks with a veritable digital identity will also bring higher trust in the platform. Furthermore, blockchain technologies will enable the creation of immutable digital “catalogues raisonnes” by contemporary artists, creating a complete list of all their works in a simple and secure manner.
“Arteia’s blockchain infrastructure will allow peer-to-peer connections between art collectors allowing direct sales,and we are looking forward implementing price predictions and trends analysis to help them make better decisions. In this sense Arteia is a real use case for blockchain technologies: offering transparency and liquidity on the market, it will allow people, to use art as an investment in a rapidly changing digital age,“ points out Marek Zabicki, CTO Arteia.
SOURCE Arteia
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Fintech4 days agoHow to identify authenticity in crypto influencer channels
-
Latest News7 days ago
BMO Announces Election of Board of Directors
-
Latest News4 days ago
HSBC-backed fintech Monese is considering splitting its operations as it grapples with increasing losses.
-
Latest News3 days ago
EverBank has announced a groundbreaking partnership with Finzly, poised to revolutionize payment processing.
-
Latest News3 days ago
FinTech leaders express caution regarding the promises made in #Budget2024 concerning open banking, stating that the “devil is in the details.”
-
Latest News3 days ago
Gotion High-tech’s operating profit up 391% in 2023, nearly RMB 2.8 billion invested in R&D for the year
-
Latest News3 days ago
Aurionpro Solutions acquires Arya.ai, to power next generation Enterprise AI platforms for Financial Institutions
-
Latest News4 days ago
Wells Fargo, a leading financial institution, is set to revolutionize its trade finance operations by incorporating artificial intelligence (AI) technology through its collaboration with TradeSun.